TITLE

Advisers vote against declaring dextromethorphan a controlled substance

AUTHOR(S)
Traynor, Kate
PUB. DATE
November 2010
SOURCE
American Journal of Health-System Pharmacy;11/1/2010, Vol. 67 Issue 21, p1788
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on the voting of the U.S. Food & Drug Administration's (FDA) Drug Safety and Risk Management Committee against listing dextromethorphan as a controlled substance. It looks at how such drug became headlines in the U.S. and how the Drug Enforcement Administration (DEA) considers dextromethorphan a drug of concern. It further notes the assertion of most members that the abuse utilization of such drug does not warrant the use of Controlled Substances Act to address the issue.
ACCESSION #
54607052

 

Related Articles

  • FDA Petitions for 23% More Funds. Reed, Vita // Orange County Business Journal;8/30/2010, Vol. 33 Issue 35, p20 

    The article reports on the move of the U.S. Food and Drug Administration (FDA) to request more than 4 billion dollars for the promotion and protection of health as part of the fiscal year 2011 budget of President Barack Obama.

  • Shuren to Congress: cuts under budget sequester 'are killing us'. McCARTY, MARK // Medical Device Daily;11/18/2013, Vol. 17 Issue 223, p1 

    The article reports on the feedback given by Jeff Shuren, director of the device center at the Food and Drug Administration (FDA), regarding the impact of the budget sequester on their vital programs. It presents statistics from the Congressional Budget Office pertaining to deficit in fiscal...

  • Role of the U.S. Food and Drug Administration in the Regulatory Management of Human Listeriosis in the United States. Klontz, Karl C.; McCarthy, Patric V.; Datta, Atin R.; Lee, Judy O.; Acheson, David W. K.; Brackett, Robert E. // Journal of Food Protection;Jun2008, Vol. 71 Issue 6, p1277 

    From 1986 to 2006, the incidence of listeriosis in the United States dropped from approximately seven to three cases per million population, a reduction that most likely reflects the joint efforts of industry, government, consumers, and academia. Herein, we describe the U.S. Food and Drug...

  • Individual Treatment IND:. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p119 

    An encyclopedia entry for the Individual Treatment IND is presented. It refers to a program established by the U.S. Food and Drug Administration (FDA) in which a person may receive an experimental drug free of charge from the pharmaceutical manufacturer with the assistance of a personal...

  • Foot liberation movement gathers momentum.  // Active Living;Sep2008, Vol. 17 Issue 5, p4 

    The article reports on the barefoot exercise trend in the U.S. It highlights the benefits of exercising in barefoot as well as precautionary measures in doing barefoot exercises. It emphasizes the development of footwear which imitates bare feet. The investigation on the claims for Detoxify Foot...

  • The EMA and the FDA form working group on patient engagement. Redfearn, Suz // CenterWatch Weekly;7/5/2016, Vol. 20 Issue 26, p1 

    The article discusses the establishment of a cluster by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) which aims to focus on patient management by providing a forum to share experiences and best practices.

  • Attorney: Regenexx presents FDA with political quandary. McCARTY, MARK // Medical Device Daily;4/25/2013, Vol. 17 Issue 80, p1 

    The article presents the highlights of the annual meeting of the Food and Drug Law Institute held in Washington, D. C. on April 24, 2013. Law professor Margaret Riley discussed the social and political issues behind the case of U.S. v. Regenerative Sciences involving the processing of stem...

  • New Medications for the Treatment of Substance Use Disorders. Westreich, Laurence M.; Finklestein, Deborah // Primary Psychiatry;Dec2008, Vol. 15 Issue 12, p73 

    Can new medications help in the treatment of substance use disorders? The short answer to that question is yes. Despite the historical resistance of addiction treaters to using medications in their treatment of addicted people, recent advances and more sophisticated methods for integrating...

  • Just Enough. Evans, Sarah; Korinek, Linnea // American Family Physician;12/1/2004, Vol. 70 Issue 11, preceding p1 

    Presents news briefs on clinical medicine as of December 1, 2004. Approval given by the U.S. Food and Drug Administration to contact lenses to be worn during sleep; Program supported by the National Institute for Occupational Safety and Health for rescue and recovery workers following the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics